Repeated introductions and intensive community transmission fueled a mumps virus outbreak in Washington State

  1. Louise Hillier Moncla  Is a corresponding author
  2. Allison Black
  3. Chase DeBolt
  4. Misty Lang
  5. Nicholas R Graff
  6. Ailyn C Pérez-Osorio
  7. Nicola F Müller
  8. Dirk Haselow
  9. Scott Lindquist
  10. Trevor Bedford  Is a corresponding author
  1. Fred Hutchinson Cancer Research Center, United States
  2. University of Washington, United States
  3. Washington State Department of Health, United States
  4. Arkansas Department of Health, United States

Abstract

In 2016/2017, Washington State experienced a mumps outbreak despite high childhood vaccination rates, with cases more frequently detected among school-aged children and members of the Marshallese community. We sequenced 166 mumps virus genomes collected in Washington and other US states, and traced mumps introductions and transmission within Washington. We uncover that mumps was introduced into Washington approximately 13 times, primarily from Arkansas, sparking multiple co-circulating transmission chains. Although age and vaccination status may have impacted transmission, our dataset could not quantify their precise effects. Instead, the outbreak in Washington was overwhelmingly sustained by transmission within the Marshallese community. Our findings underscore the utility of genomic data to clarify epidemiologic factors driving transmission, and pinpoint contact networks as critical for mumps transmission. These results imply that contact structures and historic disparities may leave populations at increased risk for respiratory virus disease even when a vaccine is effective and widely used.

Data availability

All code used to analyze data, input files for BEAST, and all code used to generate figures for this manuscript are publicly available at https://github.com/blab/mumps-wa-phylodynamics. Raw FASTQ files with human reads removed are available under SRA project number PRJNA641715. All protocols for generating sequence data as well as the consensus genomes are available at https://github.com/blab/mumps-seq. Consensus genomes have also been deposited to Genbank under accessions MT859507-MT859672.

The following data sets were generated

Article and author information

Author details

  1. Louise Hillier Moncla

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, SEATTLE, United States
    For correspondence
    lhmoncla@gmail.com
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5722-1988
  2. Allison Black

    University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Chase DeBolt

    Office of Communicable Disease Epidemiology, Washington State Department of Health, Shoreline, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Misty Lang

    Office of Communicable Disease Epidemiology, Washington State Department of Health, Shorelinee, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Nicholas R Graff

    Office of Communicable Disease Epidemiology, Washington State Department of Health, Shoreline, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Ailyn C Pérez-Osorio

    Office of Communicable Disease Epidemiology, Washington State Department of Health, Shoreline, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Nicola F Müller

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, SEATTLE, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Dirk Haselow

    Epidemiology, Arkansas Department of Health, Little Rock, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Scott Lindquist

    Office of Communicable Disease Epidemiology, Washington State Department of Health, Shoreline, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Trevor Bedford

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, United States
    For correspondence
    tbedford@fredhutch.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4039-5794

Funding

National Science Foundation (DGE-1256082)

  • Allison Black

Life Sciences Research Foundation

  • Louise Hillier Moncla

National Institutes of Health (R35 GM119774-01)

  • Trevor Bedford

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 1,375
    views
  • 176
    downloads
  • 15
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Louise Hillier Moncla
  2. Allison Black
  3. Chase DeBolt
  4. Misty Lang
  5. Nicholas R Graff
  6. Ailyn C Pérez-Osorio
  7. Nicola F Müller
  8. Dirk Haselow
  9. Scott Lindquist
  10. Trevor Bedford
(2021)
Repeated introductions and intensive community transmission fueled a mumps virus outbreak in Washington State
eLife 10:e66448.
https://doi.org/10.7554/eLife.66448

Share this article

https://doi.org/10.7554/eLife.66448

Further reading

    1. Genetics and Genomics
    2. Microbiology and Infectious Disease
    Dániel Molnár, Éva Viola Surányi ... Judit Toth
    Research Article

    The sustained success of Mycobacterium tuberculosis as a pathogen arises from its ability to persist within macrophages for extended periods and its limited responsiveness to antibiotics. Furthermore, the high incidence of resistance to the few available antituberculosis drugs is a significant concern, especially since the driving forces of the emergence of drug resistance are not clear. Drug-resistant strains of Mycobacterium tuberculosis can emerge through de novo mutations, however, mycobacterial mutation rates are low. To unravel the effects of antibiotic pressure on genome stability, we determined the genetic variability, phenotypic tolerance, DNA repair system activation, and dNTP pool upon treatment with current antibiotics using Mycobacterium smegmatis. Whole-genome sequencing revealed no significant increase in mutation rates after prolonged exposure to first-line antibiotics. However, the phenotypic fluctuation assay indicated rapid adaptation to antibiotics mediated by non-genetic factors. The upregulation of DNA repair genes, measured using qPCR, suggests that genomic integrity may be maintained through the activation of specific DNA repair pathways. Our results, indicating that antibiotic exposure does not result in de novo adaptive mutagenesis under laboratory conditions, do not lend support to the model suggesting antibiotic resistance development through drug pressure-induced microevolution.

    1. Cell Biology
    2. Microbiology and Infectious Disease
    Clément Mazeaud, Stefan Pfister ... Laurent Chatel-Chaix
    Research Article

    Zika virus (ZIKV) infection causes significant human disease that, with no approved treatment or vaccine, constitutes a major public health concern. Its life cycle entirely relies on the cytoplasmic fate of the viral RNA genome (vRNA) through a fine-tuned equilibrium between vRNA translation, replication, and packaging into new virions, all within virus-induced replication organelles (vROs). In this study, with an RNA interference (RNAi) mini-screening and subsequent functional characterization, we have identified insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) as a new host dependency factor that regulates vRNA synthesis. In infected cells, IGF2BP2 associates with viral NS5 polymerase and redistributes to the perinuclear viral replication compartment. Combined fluorescence in situ hybridization-based confocal imaging, in vitro binding assays, and immunoprecipitation coupled to RT-qPCR showed that IGF2BP2 directly interacts with ZIKV vRNA 3’ nontranslated region. Using ZIKV sub-genomic replicons and a replication-independent vRO induction system, we demonstrated that IGF2BP2 knockdown impairs de novo vRO biogenesis and, consistently, vRNA synthesis. Finally, the analysis of immunopurified IGF2BP2 complex using quantitative mass spectrometry and RT-qPCR revealed that ZIKV infection alters the protein and RNA interactomes of IGF2BP2. Altogether, our data support that ZIKV hijacks and remodels the IGF2BP2 ribonucleoprotein complex to regulate vRO biogenesis and vRNA neosynthesis.